129 related articles for article (PubMed ID: 30816538)
1. Aurora kinase inhibitor VX‑680 suppresses the proliferation and migration of HUVECs and angiogenesis.
Sun X; Niu S; Zhang Z; Wang A; Yang C; Guo Z; Hao Y; Li X; Wang X
Mol Med Rep; 2019 May; 19(5):3841-3847. PubMed ID: 30816538
[TBL] [Abstract][Full Text] [Related]
2. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
3. Effects of Pien Tze Huang on angiogenesis in vivo and in vitro.
Shen AL; Hong F; Liu LY; Lin JM; Zhuang QC; Hong ZF; Peng J
Chin J Integr Med; 2012 Jun; 18(6):431-6. PubMed ID: 22821655
[TBL] [Abstract][Full Text] [Related]
4. The antiangiogenic effects of polyisoprenylated cysteinyl amide inhibitors in HUVEC, chick embryo and zebrafish is dependent on the polyisoprenyl moiety.
Nkembo AT; Ntantie E; Salako OO; Amissah F; Poku RA; Latinwo LM; Lamango NS
Oncotarget; 2016 Oct; 7(42):68194-68205. PubMed ID: 27626690
[TBL] [Abstract][Full Text] [Related]
5. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
[TBL] [Abstract][Full Text] [Related]
6. Vascular disrupting activity of combretastatin analogues.
Porcù E; Salvador A; Primac I; Mitola S; Ronca R; Ravelli C; Bortolozzi R; Vedaldi D; Romagnoli R; Basso G; Viola G
Vascul Pharmacol; 2016 Aug; 83():78-89. PubMed ID: 27235861
[TBL] [Abstract][Full Text] [Related]
7. Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2.
Lai L; Liu J; Zhai D; Lin Q; He L; Dong Y; Zhang J; Lu B; Chen Y; Yi Z; Liu M
Br J Pharmacol; 2012 Feb; 165(4b):1084-96. PubMed ID: 21658027
[TBL] [Abstract][Full Text] [Related]
8. Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo.
Kunimasa K; Ikekita M; Sato M; Ohta T; Yamori Y; Ikeda M; Kuranuki S; Oikawa T
Cancer Sci; 2010 Nov; 101(11):2462-9. PubMed ID: 20670297
[TBL] [Abstract][Full Text] [Related]
9. γ-Tocotrienol inhibits angiogenesis of human umbilical vein endothelial cell induced by cancer cell.
Li Y; Sun WG; Liu HK; Qi GY; Wang Q; Sun XR; Chen BQ; Liu JR
J Nutr Biochem; 2011 Dec; 22(12):1127-36. PubMed ID: 21292465
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 2,4-disubstituted quinazoline derivatives with potent anti-angiogenesis activities.
Yu G; Li Z; Tang L; Xiong Q
Molecules; 2014 Jun; 19(7):8916-32. PubMed ID: 24972275
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF.
Hosseini H; Rajabibazl M; Ebrahimizadeh W; Dehbidi GR
Microvasc Res; 2015 Jan; 97():13-8. PubMed ID: 25250517
[TBL] [Abstract][Full Text] [Related]
12. Rutacecarpine Inhibits Angiogenesis by Targeting the VEGFR2 and VEGFR2-Mediated Akt/mTOR/p70s6k Signaling Pathway.
Ji L; Wu M; Li Z
Molecules; 2018 Aug; 23(8):. PubMed ID: 30111763
[TBL] [Abstract][Full Text] [Related]
13. Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation.
Cho SG; Yi Z; Pang X; Yi T; Wang Y; Luo J; Wu Z; Li D; Liu M
Cancer Res; 2009 Sep; 69(17):7062-70. PubMed ID: 19671799
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiogenesis by HC·HA, a complex of hyaluronan and the heavy chain of inter-α-inhibitor, purified from human amniotic membrane.
Shay E; He H; Sakurai S; Tseng SC
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2669-78. PubMed ID: 21228375
[TBL] [Abstract][Full Text] [Related]
15. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
Gao W; Jin K; Lan H; Han N; Cao F; Teng L
Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543
[TBL] [Abstract][Full Text] [Related]
16. Suppression of VEGF-induced angiogenesis and tumor growth by Eugenia jambolana, Musa paradisiaca, and Coccinia indica extracts.
M HR; Ghosh D; Banerjee R; Salimath BP
Pharm Biol; 2017 Dec; 55(1):1489-1499. PubMed ID: 28367666
[TBL] [Abstract][Full Text] [Related]
17. Palladium (II) complex and thalidomide intercept angiogenic signaling via targeting FAK/Src and Erk/Akt/PLCγ dependent autophagy pathways in human umbilical vein endothelial cells.
Aydinlik S; Uvez A; Kiyan HT; Gurel-Gurevin E; Yilmaz VT; Ulukaya E; Armutak EI
Microvasc Res; 2021 Nov; 138():104229. PubMed ID: 34339726
[TBL] [Abstract][Full Text] [Related]
18. Benzo[a]pyrene inhibits angiogenic factors-induced alphavbeta3 integrin expression, neovasculogenesis, and angiogenesis in human umbilical vein endothelial cells.
Li CH; Cheng YW; Hsu YT; Hsu YJ; Liao PL; Kang JJ
Toxicol Sci; 2010 Dec; 118(2):544-53. PubMed ID: 20876236
[TBL] [Abstract][Full Text] [Related]
19. CASIN and AMD3100 enhance endothelial cell proliferation, tube formation and sprouting.
Kalkan BM; Akgol S; Ak D; Yucel D; Guney Esken G; Kocabas F
Microvasc Res; 2020 Jul; 130():104001. PubMed ID: 32198058
[TBL] [Abstract][Full Text] [Related]
20. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
